Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Recruiting now · Not applicable
Conditions studied: Hearing Loss, Sensorineural
In brief
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Key facts
- Study ID
- NCT05215197
- Run by
- Pamukkale University
- People needed
- 10
- Starts
- 2022-01-31
- Expected to finish
- 2028-12-20
- Last updated by the study team
- 2026-07-14
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with sensorineural hearing loss
- Patients who will have cochlear implant surgery with CI422 electrode
You may not qualify if…
- Patients with cochlear abnormality
- Patients with auditory neuropathy
Where it is running
- Pamukkale University — Denizli, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.